UK Biobank Tender for Whole Genome Sequencing
UK Biobank requires a single sequencing provider that can offer Whole Genome Sequencing services that meet the requirements outlined in the specification.
United Kingdom-Stockport: Medical analysis services
Section I: Contracting authority
I.1)Name and addresses
1-2 Spectrum Way, Adswood
Contact person: Andrea Howard
Telephone: +44 1614755386
NUTS code: UKD35
Address of the buyer profile: https://www.mytenders.co.uk/search/Search_AuthProfile.aspx?ID=AA25607
I.4)Type of the contracting authority
Section II: Object
Whole Genome Sequencing
II.1.2)Main CPV code
II.1.3)Type of contract
UK Biobank requires a single sequencing provider that can offer Whole Genome Sequencing (WGS) services that meet the requirements outlined in the specification.
The key parameters for any bidder are as follows:
— There is up to GBP 30m funding available for the conduct of a vanguard phase of whole genome sequencing,
— The scope of the tender is for sequencing (and certain named ancillary) services only,
— The sequencing for this vanguard phase should ideally be completed by the end of 2019.
II.1.5)Estimated total value
II.1.6)Information about lots
II.2.3)Place of performance
II.2.4)Description of the procurement:
This procurement is being conducted under regulation 74 of the Public Contracts Regulations 2015 (as amended) as a light touch procedure, although we are voluntarily adopting a process akin to the open procedure. UK Biobank is issuing this tender to invite bids to conduct a vanguard phase of whole genome sequencing. The principal purpose of this vanguard phase is to inform and develop the protocols and processes for the whole genome sequencing of all UK Biobank’s 500 000 participants which is expected to take place (subject to confirmation of funding) in the next few years.
UK Biobank is a major national health resource, and a registered charity in its own right, with the aim of improving the prevention, diagnosis and treatment of a wide range of serious and life-threatening illnesses – including cancer, heart diseases, stroke, diabetes, arthritis, osteoporosis, eye disorders, depression and forms of dementia.
UK Biobank recruited 500 000 people aged between 40-69 years in 2006-2010 from across the country to take part in this project. They have undergone measures, provided blood, urine and saliva samples for future analysis, given detailed information about themselves and agreed to have their health followed. Over many years this will build into a powerful resource to help scientists discover why some people develop particular diseases and others do not.
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
There may be the need to extend the duration based upon outcomes from the vanguard phase.
II.2.10)Information about variants
II.2.11)Information about options
II.2.13)Information about European Union funds
Section III: Legal, economic, financial and technical information
III.1.2)Economic and financial standing
III.1.3)Technical and professional ability
Section IV: Procedure
IV.1.1)Type of procedure
IV.1.8)Information about the Government Procurement Agreement (GPA)
IV.2.2)Time limit for receipt of tenders or requests to participate
IV.2.4)Languages in which tenders or requests to participate may be submitted:
IV.2.7)Conditions for opening of tenders
Section VI: Complementary information
VI.1)Information about recurrence
VI.2)Information about electronic workflows
NOTE: To register your interest in this notice and obtain any additional information please visit the myTenders Web Site at http://www.myTenders.org/Search/Search_Switch.aspx?ID=206350
The buyer has indicated that it will accept electronic responses to this notice via the Postbox facility. A user guide is available at http://www.myTenders.org/sitehelp/help_guides.aspx
Suppliers are advised to allow adequate time for uploading documents and to dispatch the electronic response well in advance of the closing time to avoid any last minute problems.
1-2 Spectrum Way, Adswood
Telephone: +44 1614755386Internet address:http://www.ukbiobank.ac.uk
VI.5)Date of dispatch of this notice: